Comparing The Effects of Small Molecules BIX-01294, Bay K8644, RG-108 and Valproic Acid, and Their Different Combinations on Induction of Pluripotency Marker-Genes by Oct4 in The Mouse Brain

Overview

Journal Cell J

Specialty Cell Biology

Date 2015 Feb 17

PMID 25685732

Citations 2

Authors

Sareh Asadi

Samaneh Dehghan

Maryam Hajikaram

Seyed Javad Mowla

Abolhassan Ahmadiani Ahmadiani

Mohammad Javan

Affiliations

Soon will be listed here.

Abstract

Objective: Every cell type is characterized by a specific transcriptional profile together with a unique epigenetic landscape. Reprogramming factors such as Oct4, Klf4, Sox2 and c-Myc enable somatic cells to change their transcriptional profile and convert them to pluripotent cells. Small molecules such as BIX-01294, Bay K8644, RG-108 and valproic acid (VPA) are reported as effective molecules for enhancing induction of pluripotency in vitro, however, their effects during in vivo reprogramming are addressed in this experimental study.

Materials And Methods: In this experimental study, Oct4 expressing lentiviral particles and small molecules BIX-01294, Bay K8644 and RG-108 were injected into the right ventricle of mice brain and VPA was systematically administered as oral gavages. Animals treated with different combinations of small molecules for 7 or 14 days in concomitant with Oct4 exogenous expression were compared for expression of pluripotency markers. Total RNA was isolated from the rims of the injected ventricle and quantitative polymerase chain reaction (PCR) was performed to evaluate the expression of endogenous Oct4, Nanog, c-Myc, klf4 and Sox2 as pluripotency markers, and Pax6 and Sox1 as neural stem cell (NSC) markers.

Results: Results showed that Oct4 exogenous expression for 7 days induced pluripoten- cy slightly as it was detected by significant enhancement in expression of Nanog (p<0.05). Combinatorial administration of Oct4 expressing vector and BIX-01294, Bay K8644 and RG-108 did not affect the expression of pluripotency and NSC markers, but VPA treatment along with Oct4 exogenous expression induced Nanog, Klf4 and c-Myc (p<0.001). VPA treatment before the induction of exogenous Oct4 was more effective and significantly increased the expression of endogenous Oct4, Nanog, Klf4, c-Myc (p<0.01), Pax6 and Sox1 (p<0.001).

Conclusion: These results suggest VPA as the best enhancer of pluripotency among the chemicals tested, especially when applied prior to pluripotency induction by Oct4.

Citing Articles

In Vivo Reprogramming Using Yamanaka Factors in the CNS: A Scoping Review.

Cho H, Lee S, Seo J, Kang S, Choi W, Cho S Cells. 2024; 13(4).

PMID: 38391956 PMC: 10886652. DOI: 10.3390/cells13040343.

The Effect of Traditional Chinese Medicine on Neural Stem Cell Proliferation and Differentiation.

Qin W, Chen S, Yang S, Xu Q, Xu C, Cai J Aging Dis. 2018; 8(6):792-811.

PMID: 29344417 PMC: 5758352. DOI: 10.14336/AD.2017.0428.

References

Gottlicher M, Minucci S, Zhu P, Kramer O, SCHIMPF A, Giavara S . Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001; 20(24):6969-78. PMC: 125788. DOI: 10.1093/emboj/20.24.6969. View

Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T . Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2007; 26(1):101-6. DOI: 10.1038/nbt1374. View

Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen A . Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008; 26(7):795-7. PMC: 6334647. DOI: 10.1038/nbt1418. View

Abeliovich A, Doege C . Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron. 2009; 61(3):337-9. PMC: 3659427. DOI: 10.1016/j.neuron.2009.01.024. View

Hajkova P . Epigenetic reprogramming--taking a lesson from the embryo. Curr Opin Cell Biol. 2010; 22(3):342-50. DOI: 10.1016/j.ceb.2010.04.011. View

Geinisman Y, deToledo-Morrell L, MORRELL F, Heller R . Hippocampal markers of age-related memory dysfunction: behavioral, electrophysiological and morphological perspectives. Prog Neurobiol. 1995; 45(3):223-52. DOI: 10.1016/0301-0082(94)00047-l. View

Li W, Ding S . Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2009; 31(1):36-45. DOI: 10.1016/j.tips.2009.10.002. View

Zhang Y, Li W, Laurent T, Ding S . Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci. 2013; 125(Pt 23):5609-20. PMC: 4067267. DOI: 10.1242/jcs.096032. View

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

10.

Nie B, Wang H, Laurent T, Ding S . Cellular reprogramming: a small molecule perspective. Curr Opin Cell Biol. 2012; 24(6):784-92. PMC: 3790462. DOI: 10.1016/j.ceb.2012.08.010. View

11.

Issa A, Rowe W, Gauthier S, Meaney M . Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci. 1990; 10(10):3247-54. PMC: 6570181. View

12.

Medvedev S, Grigoreva E, Shevchenko A, Malakhova A, Dementyeva E, Shilov A . Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev. 2010; 20(6):1099-112. DOI: 10.1089/scd.2010.0249. View

13.

Shi Y, Desponts C, Do J, Hahm H, Scholer H, Ding S . Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell. 2008; 3(5):568-74. DOI: 10.1016/j.stem.2008.10.004. View

14.

Kim J, Sebastiano V, Wu G, Arauzo-Bravo M, Sasse P, Gentile L . Oct4-induced pluripotency in adult neural stem cells. Cell. 2009; 136(3):411-9. DOI: 10.1016/j.cell.2009.01.023. View

15.

Yamanaka S . Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009; 460(7251):49-52. DOI: 10.1038/nature08180. View

16.

Korbling M, Estrov Z . Adult stem cells for tissue repair - a new therapeutic concept?. N Engl J Med. 2003; 349(6):570-82. DOI: 10.1056/NEJMra022361. View

17.

Driscoll I, Hamilton D, Petropoulos H, Yeo R, Brooks W, Baumgartner R . The aging hippocampus: cognitive, biochemical and structural findings. Cereb Cortex. 2003; 13(12):1344-51. DOI: 10.1093/cercor/bhg081. View

18.

Blelloch R, Venere M, Yen J, Ramalho-Santos M . Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell. 2008; 1(3):245-7. PMC: 2894698. DOI: 10.1016/j.stem.2007.08.008. View

19.

Shi Y, Do J, Desponts C, Hahm H, Scholer H, Ding S . A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2008; 2(6):525-8. DOI: 10.1016/j.stem.2008.05.011. View